Back to News
Market Impact: 0.1
Sensei Biotherapeutics, Inc. Appoints Adam Schayowitz to Board of Directors on October 23, 2026
Source: Nasdaq
Management & Governance
On October 23, 2026, Faeth Therapeutics, Inc., also known as Sensei Biotherapeutics, Inc., expanded its Board from six to seven directors and appointed Adam Schayowitz as a Class III director, effective immediately. The article text is incomplete and provides no further details about the appointee or the appointment’s rationale.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Tech's relief rally extends as attention turns to tough decisions for the Fed
- The big takeaways and big questions from Anthropic’s S-1
- UPS Raises Outlook as CEO Plans to Stay On to Oversee Union Talks
- Walmart says AI training is boosting confidence with the technology among its 2.1 million associates
- HSBC reports third-quarter pretax profit in line with estimates on net income boost
- How is P&G’s CEO getting inflation-weary shoppers to pay more? It starts with cashmere-like diapers